Eton Pharmaceuticals (ETON) Enterprise Value (2018 - 2026)

Eton Pharmaceuticals has disclosed Enterprise Value across 9 years of filings, most recently posting $997.3 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 179.52% year-over-year to $997.3 million; the TTM figure through Jun 2026 stood at $997.3 million (up 179.52% YoY), while the FY2025 annual figure was $431.4 million, up 26.58% from the prior year.
• Enterprise Value came in at $997.3 million for Q2 2026 at Eton Pharmaceuticals, up from $431.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $997.3 million in Q2 2026 to a low of $39.7 million in Q3 2022.
• Average Enterprise Value over 5 years is $226.3 million, with a median of $91.1 million recorded in 2023.
• Year-over-year, Enterprise Value sank 60.9% in 2022 and soared 432.42% in 2025.
• Over 5 years, Enterprise Value stood at $55.2 million in 2022, then jumped by 65.11% to $91.1 million in 2023, then soared by 274.02% to $340.8 million in 2024, then increased by 26.58% to $431.4 million in 2025, then surged by 131.15% to $997.3 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $997.3 million in Q2 2026, $431.4 million in Q4 2025, and $545.6 million in Q3 2025.